Your activity: 130 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Bexarotene: Drug information

Bexarotene: Drug information

Information for this drug is presented separately based upon the following methods of administration:

Topic 8695 Version 37.0